OBJECTIVES: To review the literature on the experimental, physiological and clinical effects of blood purification with high cut-off (HCO) point membranes in septic acute renal failure (ARF). STUDY DESIGN: MEDLINE and PubMed database search combining relevant terms and integrating data from studies on the use of HCO membranes. SETTING AND POPULATION: Ex vivo studies of endotoxemia, animal studies of bacteremia and clinical studies using HCO membranes in patients with septic ARF. SELECTION CRITERIA FOR STUDIES: Original data from primary publications. INTERVENTIONS: HCO membrane-based hemodialysis, hemodiafiltration or hemofiltration. OUTCOMES: Plasma cytokine clearance, immunological and physiological effects and safety parameters of HCO membranes. RESULTS: HCO membranes effectively remove cytokines from blood. Treatment using HCO membranes has beneficial effects on immune cell function and increases survival in animal models of sepsis. Preliminary clinical studies show that HCO membranes decrease plasma cytokine levels and the need for vasopressor therapy. HCO membrane-based blood purification has now been applied in four pilot randomized controlled studies of 70 patients with septic ARF with no reports of serious adverse effects. LIMITATIONS: Because of substantial heterogeneity, no formal quantitative analysis could be performed. CONCLUSIONS: The available evidence on HCO blood purification justifies larger randomized controlled trials in patients with septic ARF.
OBJECTIVES: To review the literature on the experimental, physiological and clinical effects of blood purification with high cut-off (HCO) point membranes in septic acute renal failure (ARF). STUDY DESIGN: MEDLINE and PubMed database search combining relevant terms and integrating data from studies on the use of HCO membranes. SETTING AND POPULATION: Ex vivo studies of endotoxemia, animal studies of bacteremia and clinical studies using HCO membranes in patients with septic ARF. SELECTION CRITERIA FOR STUDIES: Original data from primary publications. INTERVENTIONS:HCO membrane-based hemodialysis, hemodiafiltration or hemofiltration. OUTCOMES: Plasma cytokine clearance, immunological and physiological effects and safety parameters of HCO membranes. RESULTS:HCO membranes effectively remove cytokines from blood. Treatment using HCO membranes has beneficial effects on immune cell function and increases survival in animal models of sepsis. Preliminary clinical studies show that HCO membranes decrease plasma cytokine levels and the need for vasopressor therapy. HCO membrane-based blood purification has now been applied in four pilot randomized controlled studies of 70 patients with septic ARF with no reports of serious adverse effects. LIMITATIONS: Because of substantial heterogeneity, no formal quantitative analysis could be performed. CONCLUSIONS: The available evidence on HCO blood purification justifies larger randomized controlled trials in patients with septic ARF.
Authors: Claudio Ronco; Zaccaria Ricci; Daniel De Backer; John A Kellum; Fabio S Taccone; Michael Joannidis; Peter Pickkers; Vincenzo Cantaluppi; Franco Turani; Patrick Saudan; Rinaldo Bellomo; Olivier Joannes-Boyau; Massimo Antonelli; Didier Payen; John R Prowle; Jean-Louis Vincent Journal: Crit Care Date: 2015-04-06 Impact factor: 9.097